Lubiprostone is a bicyclic fatty acid derived from prostaglandin E1 that activates ClC-2 chloride channels on gastrointestinal epithelial cells, promoting chloride-rich fluid secretion. It is used in the management of idiopathic chronic constipation and irritable bowel syndrome.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Lubiprostone?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Methyl 4-[(piperidin-4-yl)methyl]benzoate hydrochloride
pharmaceutical raw material
Pyrantel tartrate
pharmaceutical raw material
Etoposide
antineoplastic chemotherapeutic agent
Trimagnesium dicitrate
pharmaceutical raw material
The international HS code for Lubiprostone (CAS 333963-40-9) is 2937.50.
2937.50
2937 50 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
7-[(2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxo-3,4,4a,5,7,7a-hexahydrocyclopenta[b]pyran-5-yl]heptanoic acid
WGFOBBZOWHGYQH-MXHNKVEKSA-N
CCCCC([C@]1(CC[C@H]2[C@H](O1)CC(=O)[C@@H]2CCCCCCC(=O)O)O)(F)F
Sourcing Lubiprostone?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.